Table 5.
Association of OSA’s Treatment Status and Severity With Subfoveal Thickness.
| Coefficient | SE | P value | |
|---|---|---|---|
| Univariate linear regression of subfoveal thickness among those with only OSA or both CSC and OSA | |||
| Baseline AHI | –0.53 | 0.50 | .296 |
| Minimum nocturnal SpO2 nadir | 2.98 | 1.78 | .099 |
| ODI | –0.51 | 0.55 | .358 |
| Multivariable linear regression of subfoveal thickness by OSA treatmenta | |||
| CSC only | Reference | ||
| CSC and treated OSA | –74.73 | 47.62 | .121 |
| CSC and untreated OSA | –72.06 | 50.96 | .162 |
| OSA only | –163.56 | 25.78 | <.001 |
Abbreviations: AHI, Apnea-Hypopnea Index; CSC, central serous chorioretinopathy; ODI, Oxygen Desaturation Index; OSA, obstructive sleep apnea; SpO2, oxygen saturation,
a Adjusted for OSA severity.